p53 further extends its reach

References

• Lane DP. Cancer. p53, guardian of the genome. Nature 1992; 358:15 - 6; http://dx.doi.org/10.1038/358015a0; PMID: 1614522
   PubMed Web of Science ®Google Scholar
• Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88:323 - 31; http://dx.doi.org/10.1016/S0092-8674(00)81871-1; PMID: 9039259
   PubMed Web of Science ®Google Scholar
• Wahl GM, Linke SP, Paulson TG, Huang LC. Maintaining genetic stability through TP53 mediated checkpoint control. Cancer Surv 1997; 29:183 - 219; PMID: 9338102
   PubMedGoogle Scholar
• Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE, et al. Non-Cell-Autonomous Tumor Suppression by p53. Cell 2013; 153:449 - 60; http://dx.doi.org/10.1016/j.cell.2013.03.020; PMID: 23562644
   PubMed Web of Science ®Google Scholar
• Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6:2853 - 68; http://dx.doi.org/10.1371/journal.pbio.0060301; PMID: 19053174
   PubMed Web of Science ®Google Scholar
• Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE, et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev 2011; 25:2125 - 36; http://dx.doi.org/10.1101/gad.17276711; PMID: 21979375
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454:436 - 44; http://dx.doi.org/10.1038/nature07205; PMID: 18650914
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883 - 99; http://dx.doi.org/10.1016/j.cell.2010.01.025; PMID: 20303878
   PubMed Web of Science ®Google Scholar
• Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. ScientificWorldJournal 2011; 11:2391 - 402; http://dx.doi.org/10.1100/2011/213962; PMID: 22194670
   PubMed Web of Science ®Google Scholar
• Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012; 122:787 - 95; http://dx.doi.org/10.1172/JCI59643; PMID: 22378047
   PubMed Web of Science ®Google Scholar
• Sica A, Allavena P, Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett 2008; 267:204 - 15; http://dx.doi.org/10.1016/j.canlet.2008.03.028; PMID: 18448242
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Maeda S. Inflammation- and stress-related signaling pathways in hepatocarcinogenesis. World J Gastroenterol 2012; 18:4071 - 81; http://dx.doi.org/10.3748/wjg.v18.i31.4071; PMID: 22919237
   PubMed Web of Science ®Google Scholar
• Shirabe K, Mano Y, Muto J, Matono R, Motomura T, Toshima T, et al. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today 2012; 42:1 - 7; http://dx.doi.org/10.1007/s00595-011-0058-8; PMID: 22116397
   PubMed Web of Science ®Google Scholar
• Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009; 50:1464 - 74; http://dx.doi.org/10.1002/hep.23221; PMID: 19821482
   PubMed Web of Science ®Google Scholar
• Jing Y, Han Z, Liu Y, Sun K, Zhang S, Jiang G, et al. Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition. PLoS One 2012; 7:e43272; http://dx.doi.org/10.1371/journal.pone.0043272; PMID: 22952657
   PubMedGoogle Scholar
• van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, Huber H, et al. Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene 2009; 28:4022 - 33; http://dx.doi.org/10.1038/onc.2009.253; PMID: 19718050
   PubMed Web of Science ®Google Scholar
• Brandon-Warner E, Walling TL, Schrum LW, McKillop IH. Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol Clin Exp Res 2012; 36:641 - 53; http://dx.doi.org/10.1111/j.1530-0277.2011.01660.x; PMID: 22017344
   PubMed Web of Science ®Google Scholar
• Capece D, Fischietti M, Verzella D, Gaggiano A, Cicciarelli G, Tessitore A, et al. The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. Biomed Res Int 2013; 2013:187204; http://dx.doi.org/10.1155/2013/187204; PMID: 23533994
   PubMed Web of Science ®Google Scholar
• Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming P, et al. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression. Cancer Res 2004; 64:6058 - 64; http://dx.doi.org/10.1158/0008-5472.CAN-04-0292; PMID: 15342387
   PubMed Web of Science ®Google Scholar
• Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005; 121:977 - 90; http://dx.doi.org/10.1016/j.cell.2005.04.014; PMID: 15989949
   PubMed Web of Science ®Google Scholar
• Luedde T, Beraza N, Kotsikoris V, van Loo G, Nenci A, De Vos R, et al. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 2007; 11:119 - 32; http://dx.doi.org/10.1016/j.ccr.2006.12.016; PMID: 17292824
   PubMed Web of Science ®Google Scholar
• Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431:461 - 6; http://dx.doi.org/10.1038/nature02924; PMID: 15329734
   PubMed Web of Science ®Google Scholar